Table IV.
Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis of differentially expressed genes.
| Term | Count | P-value | Genes | FDR |
|---|---|---|---|---|
| hsa04514: Cell adhesion molecules (CAMs) | 11 | 0.0010925 | ALCAM, HLA-DQB1, HLA-DRB1, CLDN6, ICAM2, CLDN1, NTNG1, HLA-DRB5, CLDN11, CD40, CDH4 | 0.0131104 |
| hsa04020: Calcium signaling pathway | 12 | 0.0010925 | PTGER1, GNA15, ADRB2, PLCB4, TACR2, TNNC1, RYR1, OXTR, CHRNA7, NOS3, NOS2, PLCB2 | 0.0113229 |
| hsa05146: Amoebiasis | 9 | 0.0010925 | IL1R2, LAMA1, GNA15, PLCB4, SERPINB2, ACTN1, NOS2, PLCB2, FN1 | 0.0088997 |
| hsa04530: Tight junction | 9 | 0.0104316 | EPB41L3, PRKCQ, RAB3B, CLDN6, CLDN1, ACTN1, CLDN11, AMOTL1, PPP2R2C | 0.0312949 |
| hsa04940: Type I diabetes mellitus | 5 | 0.0131689 | HLA-DQB1, HLA-DRB1, PTPRN2, HLA-DRB5, PTPRN | 0.0316055 |
| hsa04672: Intestinal immune network for IgA production | 5 | 0.0192920 | HLA-DQB1, HLA-DRB1, CCR10, HLA-DRB5, CD40 | 0.0385841 |
| hsa04723: Retrograde endocannabinoid signaling | 7 | 0.0192920 | GABRG3, GNGT2, PLCB4, GABRA5, GNG4, PLCB2, GABRP | 0.0402837 |
| hsa05200: Pathways in cancer | 16 | 0.0192920 | LAMA1, FZD8, FGFR1, PTGER1, CCND1, GNGT2, PLCB4, WNT5B, APC2, PAX8, FGF12, NOS2, GNG4, PLCB2, MMP1, FN1 | 0.0384532 |
| hsa05310: Asthma | 4 | 0.0274460 | HLA-DQB1, HLA-DRB1, HLA-DRB5, CD40 | 0.0365947 |
| hsa04310: Wnt signaling pathway | 8 | 0.0321127 | FZD8, CCND1, WNT5B, NKD2, PLCB4, APC2, PLCB2, FOSL1 | 0.0385353 |
| hsa05416: Viral myocarditis | 5 | 0.0321127 | HLA-DQB1, CCND1, HLA-DRB1, HLA-DRB5, CD40 | 0.0394291 |
| hsa05330: Allograft rejection | 4 | 0.0321127 | HLA-DQB1, HLA-DRB1, HLA-DRB5, CD40 | 0.0470282 |